Relay Therapeutics Inc 2023 SR
The report highlights Relay Therapeutics' progress in 2023, focusing on its mission to develop precision medicines for oncology and genetic diseases using its Dynamo platform. Key achievements include advancing three clinical-stage programs, RLY-2608, lirafugratinib, and migoprotafib, and expanding operations across two sites in Cambridge, Massachusetts. The company emphasized its commitment to people through an inclusive culture and comprehensive benefits, and to the environment by conducting its first TCFD-aligned climate risk assessment. Additionally, Relay Therapeutics maintained high standards in clinical trial safety, product quality, and business ethics while actively engaging in community philanthropic efforts.
Company: Relay Therapeutics Inc
Sector: Professional & technical services
Country: United States
Year: 2023
Type: SR
Pages: 49
Back to company
Relay Therapeutics Inc
Corporate Responsibility Report
The report highlights Relay Therapeutics' progress in 2023, focusing on its mission to develop precision medicines for oncology and genetic diseases using its Dynamo platform. Key achievements include advancing three clinical-stage programs, RLY-2608, lirafugratinib, and migoprotafib, and expanding operations across two sites in Cambridge, Massachusetts. The company emphasized its commitment to people through an inclusive culture and comprehensive benefits, and to the environment by conducting its first TCFD-aligned climate risk assessment. Additionally, Relay Therapeutics maintained high standards in clinical trial safety, product quality, and business ethics while actively engaging in community philanthropic efforts.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Women on Board
Women in Management
Workplace Fatalities
Employees